Dr. Leora Fox keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

STAT Article: HD Clinical Trials Bring Hope

Posted on December 5, 2019

This week an article in STAT talks about the ongoing Roche GENERATION-HD1 trial. The story explains Huntington’s disease and covers the experiences…

Read More

Happy Thanksgiving from HDSA

Posted on November 27, 2019

Happy Thanksgiving from all of us at HDSA! We are especially grateful for your engagement in research – it’s how medicine moves…

Read More

The Marker: HDSA’s 2019 Research Report

Posted on November 21, 2019

Each year, HDSA prepares a report that covers what happened in HD research this year. This year, The Marker includes HDSA research activities…

Read More

HSG Announces New Phase 3 Study To Test Drug For HD Chorea

Posted on November 13, 2019

The Huntington Study Group issued a press release about a new study to treat the movements associated with HD, known as chorea….

Read More

Scientists Experiment with a New Huntingtin-Lowering Strategy

Posted on November 7, 2019

The huntingtin-lowering drugs in clinical trials right now are focused on attacking mutant huntingtin on the RNA level – essentially…

Read More

Insights on HD Age of Onset

Posted on October 31, 2019

Several groups of scientists have reported recently on how CAG length “hiccups” or expansions during life can influence the age of…

Read More

World’s First HD Gene Therapy Trial

Posted on October 24, 2019

Boston-based company uniQure is conducting the first HD gene therapy trial of their drug AMT-130. The Phase 1/2 trial is designed to test…

Read More

HDSA Names Five 2019 HD Human Biology Project Fellows

Posted on October 17, 2019

This week, we announced the winners of the 2019 HD Human Biology Fellowship. These young scientists were chosen for their…

Read More

This Week in HD History: Remembering Marjorie Guthrie

Posted on October 10, 2019

On October 6th, 1917, HDSA’s founder Marjorie Guthrie was born. Not only did Marjorie found the Committee to Combat Huntington’s…

Read More

This Week in HD History: Huntingtin Aggregates

Posted on October 3, 2019

One of the telltale signs of Huntington’s disease is the clumps of huntingtin protein that build up all over the…

Read More

Meeting of HDSA’s Scientific Advisory Board

Posted on September 26, 2019

HDSA’s Scientific Advisory Board will gather this week at our national offices in New York City to discuss this year’s…

Read More

Last Chance to Participate in HDSA’s Survey About PGD-IVF

Posted on September 19, 2019

HDSA’s PGD-IVF survey is closing on September 20th – please add your voice so that we can best serve the…

Read More

Why Families Are Critical To HD Research

Posted on September 12, 2019

Ever wonder why HDSA and the HD research community is always talking about Enroll-HD? Are you curious about the HD…

Read More

New HD Research Survey on Occupational Therapy

Posted on September 5, 2019

Occupational therapists at CUNY York College are conducting a 5-minute survey of both patients and caregivers that seeks to understand…

Read More

Turning Off the Cause of Huntington’s Disease

Posted on August 29, 2019

Blogger and HD advocate “Gene Veritas” shared a post this week about gene editing and an upcoming gene therapy symposium…

Read More

“Hiccup” in HD Gene Contributes to Age of HD Onset

Posted on August 22, 2019

The age that Huntington’s disease symptoms appear can vary a lot from person to person. For decades, scientists have been…

Read More

HDSA Accepting Letters of Interest for 2020 Centers of Excellence Program

Posted on August 15, 2019

HDSA’s Centers of Excellence (COEs) provide multidisciplinary care services to families affected by Huntington’s disease, including neurology, psychology, genetic counseling,…

Read More

Participate in HDSA’s Survey About PGD-IVF

Posted on August 8, 2019

HDSA is committed to providing individuals and families impacted by HD with the resources they need to make informed choices….

Read More

PRECISION-HD2 Results from Wave Life Sciences Expected in Late 2019

Posted on August 1, 2019

Wave Life Sciences is conducting two early safety studies of huntingtin-lowering therapies, called PRECISION-HD1 and PRECISION-HD2. In a business update…

Read More

HD Legacy: Brain Donation for HD Research

Posted on July 25, 2019

To enable cutting-edge Huntington’s disease research, HDSA is collaborating with CHDI to support the donation of brain and other organs…

Read More